Zydus Cadila receives tentative approval from USFDA for Adapalene and Benzoyl Peroxide Gel

Zydus Cadila receives tentative approval from USFDA for Adapalene and Benzoyl Peroxide Gel Ahmedabad, India, 8 October, 2021 Zydus Cadila has received tentative approval from the USFDA to market Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%. (USRLD: Epiduo Forte). Adapalene and Benzoyl Peroxide combination is used to treat acne. It works by killing the bacteria that cause acne and by keeping the skin pores clean. The drug will be manufactured at the group’s Topical plant at Ahmedabad. The group now has 323 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04. About Zydus Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 23000 people worldwide and is dedicated to creating healthier communities globally. ***

The release as fetched from its publisher. zyduslife.com ↗